Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 6, Pages 5202
Publisher
MDPI AG
Online
2023-03-09
DOI
10.3390/ijms24065202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis
- (2021) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delamanid or pretomanid? A Solomonic judgement!
- (2021) Saskia E. Mudde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The quest for the holy grail: new antitubercular chemical entities, targets and strategies
- (2020) Stanislav Huszár et al. DRUG DISCOVERY TODAY
- MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
- (2020) Giovanni Battista Migliori et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
- (2020) Norimitsu Hariguchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis
- (2020) Bodhraj Acharya et al. MOLECULAR BIOLOGY REPORTS
- The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications
- (2020) Laneke Luies et al. CLINICAL MICROBIOLOGY REVIEWS
- Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead
- (2020) Eduardo M. Bruch et al. Applied Sciences-Basel
- Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
- (2019) Wei Li et al. ACS Infectious Diseases
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II
- (2019) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
- (2019) Bing Zhang et al. CELL
- 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
- (2019) Hamish S. Sutherland et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
- (2019) Chih-Chia Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- (2019) Payam Nahid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis
- (2018) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
- (2018) Rupesh V. Chikhale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases
- (2018) Qiyao Chai et al. Frontiers in Cellular and Infection Microbiology
- Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis
- (2018) Xiaoyun Lu et al. ACS Infectious Diseases
- MmpL3 is the flippase for mycolic acids in mycobacteria
- (2017) Zhujun Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
- (2017) Giulia Degiacomi et al. Scientific Reports
- Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
- (2016) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on pulmonary disease due to non-tuberculous mycobacteria
- (2016) Jason E. Stout et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosis
- (2016) Hermann Giresse Tima et al. Journal of Innate Immunity
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis
- (2016) Misty L. Kuhn et al. ACS Infectious Diseases
- DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization
- (2015) Miroslav Brecik et al. ACS Chemical Biology
- The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis
- (2015) Vadim Makarov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening
- (2015) Ujjini H. Manjunatha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis
- (2015) Anca Dorhoi et al. Seminars in Immunopathology
- Crystal structure of FadD32, an enzyme essential for mycolic acid biosynthesis in mycobacteria
- (2015) Wenjuan Li et al. Scientific Reports
- Tuberculosis Treatment and Drug Regimens
- (2015) G. Sotgiu et al. Cold Spring Harbor Perspectives in Medicine
- The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets
- (2015) K. Mdluli et al. Cold Spring Harbor Perspectives in Medicine
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
- (2015) Alimuddin Zumla et al. Lancet Respiratory Medicine
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
- (2014) Monalisa Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ATP synthase in mycobacteria: Special features and implications for a function as drug target
- (2014) Ping Lu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- The Polyketide Synthase Pks13 Catalyzes a Novel Mechanism of Lipid Transfer in Mycobacteria
- (2014) Sabine Gavalda et al. CHEMISTRY & BIOLOGY
- Mycolic Acids: Structures, Biosynthesis, and Beyond
- (2014) Hedia Marrakchi et al. CHEMISTRY & BIOLOGY
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents
- (2014) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway inMycobacterium tuberculosisusing conditional mutants
- (2014) Gaëlle S. Kolly et al. MOLECULAR MICROBIOLOGY
- Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32
- (2013) Tomohiko Kawate et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
- (2013) Thomas R. Ioerger et al. PLoS One
- Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
- (2013) S. A. Stanley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
- (2012) Cristian Varela et al. CHEMISTRY & BIOLOGY
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Tuberculosis and HIV Co-Infection
- (2012) Andrzej Pawlowski et al. PLoS Pathogens
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Tuberculosis Pathogenesis and Immunity
- (2011) Jennifer A. Philips et al. Annual Review of Pathology-Mechanisms of Disease
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
- (2011) Valentina La Rosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying Vulnerable Pathways in Mycobacterium tuberculosis by Using a Knockdown Approach
- (2011) Paul Carroll et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- The structure–activity relationship of urea derivatives as anti-tuberculosis agents
- (2011) Joshua R. Brown et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?
- (2011) Stephen T Reece et al. CURRENT OPINION IN MICROBIOLOGY
- Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
- (2011) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Pathology of post primary tuberculosis of the lung: An illustrated critical review
- (2011) Robert L. Hunter TUBERCULOSIS
- Drug-resistant tuberculosis: Past, present, future
- (2010) Chen-Yuan CHIANG et al. RESPIROLOGY
- The Arabinosyltransferase EmbC Is Inhibited by Ethambutol in Mycobacterium tuberculosis
- (2009) R. Goude et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids inMycobacterium tuberculosis
- (2009) Sabine Gavalda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Foamy macrophages and the progression of the human tuberculosis granuloma
- (2009) David G Russell et al. NATURE IMMUNOLOGY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence
- (2008) Pascale Peyron et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started